Saturday, July 23, 2011 1:26:58 PM
CYCC-bullish analysis
CYCC gained 5.17% on 07/22/11 and a total percentage of 7.96% in the past 2 days
CYCC is trading in the range of $1.12 - $1.40 in the past 30 days.
Average True Range (Atr) indicates the volatility has increased for CYCC.
Commodity Channel Index (CCI) is bullish for CYCC.
CYCC formed a Bullish Macd Crossover signal.
Money Flow Index (MFI) is bullish and moving up for CYCC.
CYCC formed a bullish Price & Exponential Moving Average Crossover signal.
CYCC formed a bullish Price & Simple Moving Average Crossover signal.
The 10-day simple moving average is bearish and moving down for CYCC.
CYCC formed a bullish Stochastic Crossover signal.
CYCC gained 5.17% on 07/22/11 and a total percentage of 7.96% in the past 2 days
CYCC is trading in the range of $1.12 - $1.40 in the past 30 days.
Average True Range (Atr) indicates the volatility has increased for CYCC.
Commodity Channel Index (CCI) is bullish for CYCC.
CYCC formed a Bullish Macd Crossover signal.
Money Flow Index (MFI) is bullish and moving up for CYCC.
CYCC formed a bullish Price & Exponential Moving Average Crossover signal.
CYCC formed a bullish Price & Simple Moving Average Crossover signal.
The 10-day simple moving average is bearish and moving down for CYCC.
CYCC formed a bullish Stochastic Crossover signal.
Recent CYCC News
- Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd. • GlobeNewswire Inc. • 09/12/2025 10:00:00 AM
- Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2025 08:05:00 PM
- CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB • GlobeNewswire Inc. • 08/04/2025 10:50:00 PM
- Cyclacel stock dips after trimming 270% surge amid volatility concerns • IH Market News • 07/16/2025 03:09:18 PM
- CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY • GlobeNewswire Inc. • 07/16/2025 01:00:00 PM
- Cyclacel Stock Surges 50% After Amending Exchange Agreement with FITTERS • IH Market News • 07/07/2025 01:34:48 PM
- CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER • GlobeNewswire Inc. • 07/07/2025 10:00:00 AM
- CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT • GlobeNewswire Inc. • 07/07/2025 10:00:00 AM
- Cyclacel Pharmaceuticals Announces Stock Split • GlobeNewswire Inc. • 07/02/2025 01:00:00 PM
- Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock • GlobeNewswire Inc. • 06/20/2025 08:30:00 PM
- CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT • GlobeNewswire Inc. • 06/03/2025 08:15:00 PM
- CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE • GlobeNewswire Inc. • 05/15/2025 04:50:00 AM
